Together we will beat cancer

Donate

Myeloma maintenance treatment not recommended on NHS in England

Cancer drug lenalidomide receives an initial rejection to treat some adults with myeloma following a stem cell transplant.

Read More

New treatment for rare blood cancer approved for NHS use in England

The National Institute for Health and Care Excellence (NICE) has approved the drug brentuximab vedotin on the NHS in England.

Read More

CAR T cell immunotherapy now available through NHS Scotland for some adults with lymphoma

A personalised immunotherapy treatment will now be available in Scotland for some adults living with an aggressive form of lymphoma.

Read More

New treatment option for certain leukaemia patients in Scotland

A targeted combination treatment for patients with a specific type of blood cancer will soon be available on the NHS in Scotland.

Read More

NICE U-turn opens up new treatment option for some adults with leukaemia

Patients living with a specific type of leukaemia will have access to a new immunotherapy treatment on the NHS in England.

Read More

Double NHS decision for CAR T cell immunotherapy in Scotland

Two cancer immunotherapies have been reviewed for NHS use in Scotland as a treatment for some patients with aggressive blood cancer.

Read More

‘Magic’ blood test could make bone marrow transplants for blood cancer safer

A blood test could help predict the risk of complication following a bone marrow transplant in some blood cancer patients, according to a new US study.

Read More

Acute myeloid leukaemia is 11 different diseases

Researchers studying the genetic make-up of an aggressive blood cancer, AML, have discovered that it exists in at least 11 different forms.

Read More